These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17700685)

  • 21. In a flurry of PINK, mitochondrial bioenergetics takes a leading role in Parkinson's disease.
    Murphy AN
    EMBO Mol Med; 2009 May; 1(2):81-4. PubMed ID: 20049706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel protein degradation system in young-onset Parkinson's disease: mitophagy is a therapeutic target as a quality control for damaged mitochondria.
    Hatano T
    Mov Disord; 2011 Apr; 26(5):773. PubMed ID: 21671510
    [No Abstract]   [Full Text] [Related]  

  • 23. Bumping up kinase activity with an ATP-derived neo-substrate.
    Kleiner RE; Kapoor TM
    Cell; 2013 Aug; 154(4):716-8. PubMed ID: 23953104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in the mechanisms of Parkinson's disease.
    Tolleson CM; Fang JY
    Discov Med; 2013 Jan; 15(80):61-6. PubMed ID: 23375015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What does PINK1 mean for Parkinson diseases?
    Singleton A
    Neurology; 2004 Oct; 63(8):1350-1. PubMed ID: 15505146
    [No Abstract]   [Full Text] [Related]  

  • 26. PINK1 mutations: does the dosage make the poison?
    Scholz SW
    Hum Mutat; 2009 Nov; 30(11):v. PubMed ID: 19862834
    [No Abstract]   [Full Text] [Related]  

  • 27. Physiology versus pathology in Parkinson's disease.
    Nakamura K; Edwards RH
    Proc Natl Acad Sci U S A; 2007 Jul; 104(29):11867-8. PubMed ID: 17623781
    [No Abstract]   [Full Text] [Related]  

  • 28. Parkinson's disease in the PINK.
    Bradbury J
    Drug Discov Today; 2004 Jun; 9(12):508-9. PubMed ID: 15183154
    [No Abstract]   [Full Text] [Related]  

  • 29. PINK1 mutations and differential effects on mitochondrial function.
    Tan EK
    Exp Neurol; 2010 Jan; 221(1):10-2. PubMed ID: 19879875
    [No Abstract]   [Full Text] [Related]  

  • 30. PINK1 is involved in determining the cellular autophagic hierarchy.
    Zhou Z; Chen Z; Zheng Y
    Sci China Life Sci; 2024 May; 67(5):1087-1088. PubMed ID: 38324130
    [No Abstract]   [Full Text] [Related]  

  • 31. Mitochondria back in the spotlight in Parkinson's disease.
    Love R
    Lancet Neurol; 2004 Jun; 3(6):326. PubMed ID: 15176404
    [No Abstract]   [Full Text] [Related]  

  • 32. The Arabidopsis skp1-like1-1 (ask1-1) mutant and the mouse cells of a sporadic Parkinson's disease model created with downregulation of SKP1 share similar cellular defects.
    Wang Y; Yang M
    Parkinsonism Relat Disord; 2012 Jan; 18(1):102-3. PubMed ID: 21775187
    [No Abstract]   [Full Text] [Related]  

  • 33. PINK spots: diseased mitochondria prepare for mitophagy.
    Osman S
    Nat Struct Mol Biol; 2022 Feb; 29(2):82. PubMed ID: 35145324
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical and demographic characteristics of PINK1 mutation carriers--a meta-analysis.
    Kasten M; Weichert C; Lohmann K; Klein C
    Mov Disord; 2010 May; 25(7):952-4. PubMed ID: 20461815
    [No Abstract]   [Full Text] [Related]  

  • 35. What's wrong with mitochondria in Parkinson's disease?
    Greenamyre JT
    Mov Disord; 2018 Oct; 33(10):1515-1517. PubMed ID: 30288798
    [No Abstract]   [Full Text] [Related]  

  • 36. Unraveling PINK1 regulation: Ubiquitination of its mature form and insights for Parkinson's disease.
    Saeed U; Masellis M
    Mov Disord; 2017 Nov; 32(11):1546. PubMed ID: 28976028
    [No Abstract]   [Full Text] [Related]  

  • 37. Infection triggers symptoms similar to those of Parkinson's disease in mice lacking PINK1 protein.
    Herrick MK; Tansey MG
    Nature; 2019 Jul; 571(7766):481-482. PubMed ID: 31337898
    [No Abstract]   [Full Text] [Related]  

  • 38. No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson's disease.
    Gaare JJ; Nido GS; Sztromwasser P; Knappskog PM; Dahl O; Lund-Johansen M; Alves G; Tysnes OB; Johansson S; Haugarvoll K; Tzoulis C
    Brain; 2018 Mar; 141(3):e16. PubMed ID: 29373637
    [No Abstract]   [Full Text] [Related]  

  • 39. Reply: No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson's disease.
    Fitzgerald JC; Zimprich A; Reddy Bobbili D; Sharma M; May P; Krüger R
    Brain; 2018 Mar; 141(3):e17. PubMed ID: 29373630
    [No Abstract]   [Full Text] [Related]  

  • 40. Promising disease-modifying therapies for Parkinson's disease.
    Dawson VL; Dawson TM
    Sci Transl Med; 2019 Nov; 11(520):. PubMed ID: 31776289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.